Generate a tailored SOP for Dr. Gerry Lipshutz. Improve your application with a focused, well-structured draft.
Gerry Lipshutz is a Professor in the Department of Pharmacology at UCLA. His research focuses on the development of gene and cell-based therapies for the treatment of metabolic diseases of the liver, which commonly lead to the development of intellectual disabilities in children. His active research directions include the development of gene-based therapies, such as adeno-associated virus and mRNA therapies, aimed at restoring nitrogen metabolism and ureagenesis. He is also exploring the underlying neurobiology associated with arginase deficiency to gain a greater understanding of the neuropathology that exists due to enzyme deficiency. With academic training from UCSF, he has been a faculty member at UCLA since 2004, contributing significantly to the field of pharmacology and metabolic diseases.
Department of Economics admits primarily for the PhD program.